Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.53B | 1.45B | 1.40B | 2.69B | 3.70B | Gross Profit |
1.53B | 1.40B | 1.31B | 2.54B | 3.60B | EBIT |
351.00M | -282.00M | -598.00M | 1.11B | 738.00M | EBITDA |
0.00 | 0.00 | -420.00M | 1.31B | 872.00M | Net Income Common Stockholders |
248.00M | 1.00M | -549.00M | 994.00M | 833.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.33B | 1.20B | 1.16B | 1.94B | 1.52B | Total Assets |
7.72B | 8.03B | 9.25B | 11.42B | 10.48B | Total Debt |
597.00M | 1.03B | 624.00M | 706.00M | 840.00M | Net Debt |
-738.00M | -167.00M | -532.00M | -1.23B | -717.00M | Total Liabilities |
2.68B | 3.15B | 3.37B | 706.00M | 3.67B | Stockholders Equity |
5.03B | 4.88B | 5.87B | 7.85B | 6.81B |
Cash Flow | Free Cash Flow | |||
180.00M | 162.00M | 83.00M | 2.00M | 31.00M | Operating Cash Flow |
213.00M | 221.00M | 110.00M | 14.00M | 56.00M | Investing Cash Flow |
258.00M | 542.00M | -86.00M | 755.00M | 1.01B | Financing Cash Flow |
-342.00M | -711.00M | -761.00M | -243.00M | -1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | £154.57B | 10.36 | 10.86% | 5.79% | -3.40% | -7.51% | |
79 Outperform | £10.21B | 15.40 | 56.17% | 5.76% | 34.86% | 95.18% | |
67 Neutral | £6.49B | ― | -60.34% | 8.31% | -6.33% | ― | |
66 Neutral | $5.77B | 30.42 | -10.00% | 7.89% | 28.69% | -220.08% | |
64 Neutral | $12.86B | 9.79 | 7.78% | 16985.65% | 12.28% | -7.82% | |
63 Neutral | £3.27B | 13.90 | 4.88% | 7.96% | -5.51% | 1596.15% | |
58 Neutral | £14.65B | 88.62 | 4.06% | 8.34% | -21.56% | -61.14% |